EP2898887
Samsetning af telómerasahindra og gemsítabíni til meðhöndlunar á krabbameini
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
30.10.2007EP published:
26.9.2018EP application number:
14198829.5
EP translation filed:
24.10.2018Grant published:
15.11.2018EPO information:
European Patent Register
Max expiry date:
29.10.2027Expiry date:
29.10.2025Next due date:
31.10.2025
Title:
Combined telomerase inhibitor and gemcitabine for the treatment of cancer
Timeline
Today
30.10.2007EP application
26.9.2018EP Publication
24.10.2018Translation submitted
15.11.2018Registration published
29.10.2025Expires
Owner
Name:
GERON CORPORATIONAddress:
149 Commonwealth Drive, 94025, Menlo Park, CA, US
Inventor
Name:
Go, NingAddress:
Thousands Oaks, CA, US
Name:
Tressler, Robert J.Address:
Capitola, CA, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
855583 PDate:
30.10.2006Country:
US
Classification
Categories:
A61K 31/70
Annual fees
Number
Paid
Expires
Payer
Number: 12
Paid: 7.11.2018
Expires: 29.10.2019
Payer: Árnason Faktor
Number: 13
Paid: 9.9.2019
Expires: 29.10.2020
Payer: Árnason Faktor
Number: 14
Paid: 9.9.2020
Expires: 29.10.2021
Payer: Árnason Faktor ehf.
Number: 15
Paid: 7.9.2021
Expires: 29.10.2022
Payer: Árnason Faktor ehf.
Number: 16
Paid: 7.9.2022
Expires: 29.10.2023
Payer: Árnason Faktor ehf.
Number: 17
Paid: 13.10.2023
Expires: 29.10.2024
Payer: Árnason Faktor ehf.
Number: 18
Paid: 17.9.2024
Expires: 29.10.2025
Payer: Árnason Faktor ehf.